Business Context and Reporting Period
Company: Annaly Capital Management, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 20, 2024
Event: Entry into Material Definitive Agreements for an "at-the-market" equity offering program.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It details a new capital raising facility.
- Offering Capacity: Up to $1,500,000,000 in aggregate offering price of Common Stock.
- Commission Rate: Up to 1.25% of the gross sales price per share sold through Sales Agents.
- Securities Involved: Common Stock, par value $0.01 per share (Trading Symbol: NLY).
Material Changes
The Company entered into separate Distribution Agency Agreements with eleven financial institutions (Barclays, BNP Paribas, BofA, Citizens JMP, Goldman Sachs, J.P. Morgan, Keefe Bruyette & Woods, Morgan Stanley, RBC Capital Markets, UBS, and Wells Fargo). This establishes a mechanism to sell shares from time to time through these agents in "at-the-market" offerings.
Guidance, Outlook, and Risks
Management Commentary: The Company may offer and sell shares at its election. Sales Agents will use commercially reasonable efforts consistent with normal sales and trading practices.
Contingencies: Sales are subject to customary conditions, representations, warranties, and termination provisions outlined in the agreements.
Risks: The filing notes that the description of the agreements is qualified by reference to the full text of the agreements attached as exhibits. No specific financial risks or outlook guidance regarding future earnings are provided in this document.
Investor Verification Checklist
- Verify the current market price of NLY Common Stock to assess potential dilution impact from the $1.5 billion offering capacity.
- Review the attached Distribution Agency Agreements (Exhibits 1.1 through 1.11) for specific termination rights and conditions.
- Monitor future filings to determine the actual volume of shares sold under this program and the timing of sales.
- Confirm the status of the automatic shelf registration statement (Form S-3 No. 333-282261) referenced in the filing.